Last updated: February 27, 2026
What is NDC 51285-0366?
NDC 51285-0366 refers to a specific drug product registered with the National Drug Code system. Based on current data, this code corresponds to [Drug Name], which is indicated for [Therapeutic Use].
Note: Specific drug details such as formulation, dosage, and manufacturer are required for precise analysis.
Market Overview
Industry Context
The drug market for [Therapeutic Area] is characterized by high competition, rapid innovation, and regulatory scrutiny. Market entrants include innovators with novel mechanisms and established players with generics.
Market Size
As of 2022, the global market for [Therapeutic Area] therapies was valued at approximately $X billion, projected to grow at a CAGR of Y% through 2027. The U.S. accounts for roughly Z% of this market.
Key Competitors
- Brand Name Drugs: Dominating market share with A%.
- Generic Companies: Increasing presence, capturing B%.
- Emerging Biosimilars: Entering the market with regulatory approvals and price advantages.
Regulatory Status
NDC 51285-0366 has been approved by the FDA since [Approval Date]. The approval was based on [clinical trial data] demonstrating [efficacy/safety profile].
Price Trends and Projections
Current Pricing Landscape
| Product |
Average Wholesale Price (AWP) |
Estimated Annual Cost per Patient |
| NDC 51285-0366 |
$X |
$Y |
| Brand A |
$X+ |
$Y+ |
| Generic B |
$X- |
$Y- |
The current price for NDC 51285-0366 aligns with mid-tier European and U.S. generics, approximately $X per unit.
Price Drivers
- Patent Status: Patent expiration or extensions influence pricing. Patent protection until [Date] maintains premium pricing.
- Manufacturing Costs: Increased costs for active pharmaceutical ingredients (API) push prices upward.
- Market Competition: Entry of generics or biosimilars could reduce prices by 10-30% within 1-2 years after approval.
- Regulatory Changes: Potential for price regulation or negotiation under healthcare reforms.
Future Price Projections
Using current data and market dynamics, the expected price trajectory is as follows:
| Year |
Estimated Price Range |
Key Factors |
| 2023 |
$X - $Y |
Stable, with slight increases due to inflation |
| 2024 |
$X - $Y- |
Entry of generic competitors, price pressure |
| 2025 |
$X - $Y- |
Possible price erosion, depending on patent status |
| 2026+ |
$[Lower bound] - $[Upper bound]** |
Market saturation, biosimilar competition |
Market Penetration and Revenue Potential
Initial penetration is expected to be [X%] within the first year post-approval. Long-term revenue depends on:
- Market share capture,
- Reimbursement rates,
- Compound patent or exclusivity extensions.
Projected annual revenue could reach $[Estimate] if market uptake aligns with historical trends for similar drugs.
Risks and Opportunities
Risks
- Patent expiry and generic competition,
- Reimbursement and formulary restrictions,
- Regulatory challenges or delays.
Opportunities
- Expanding indications,
- Strategic partnerships,
- Price optimization through value-based agreements.
Key Takeaways
- NDC 51285-0366 is positioned within a highly competitive therapeutic market.
- Current pricing is approximately $X per unit with potential for reduction linked to generic entry.
- Market size growth is driven by demand for [Therapeutic Area] medications, with projected CAGR of Y%.
- Revenue potential depends on market penetration, reimbursement policies, and regulatory developments.
- Price erosion could accelerate post-patent expiration, necessitating strategic planning for long-term viability.
FAQs
1. When will patent expiry likely affect NDC 51285-0366?
Patent protection is valid until [Date], after which generic competition is expected to emerge.
2. What factors will influence the drug's market share?
Market share depends on clinical efficacy, safety profile, pricing strategy, and reimbursement negotiations.
3. Are biosimilars a threat to this drug?
Biosimilars could impact pricing and market share once approved, typically within 8-10 years post-original approval.
4. How do regulatory changes affect pricing projections?
Pricing could decrease if policies favor price controls or value-based pricing models.
5. What are key considerations for investment in this drug?
Evaluation of patent status, competitive landscape, regulatory eligibility, and market demand is essential.
Sources
- [Source 1: Industry Reports on Market Value & CAGR]
- [Source 2: FDA Database for Regulatory Status & Approval]
- [Source 3: Wholesale Price Indexes; Drug Price Analytics]
- [Source 4: Patent and Exclusivity Data; USPTO records]
- [Source 5: Competitive Landscape Analyses, Industry News]
